Shares of BridgeBio Pharma (Nasdaq: BBIO) are down nearly 70% today after the company announced topline results from Month 12 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE